Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dolby Laboratories (DLB) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Dolby Laboratories (DLB) over the last 17 years, with Q4 2025 value amounting to $643.8 million.

  • Dolby Laboratories' Cash & Equivalents rose 2362.12% to $643.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $643.8 million, marking a year-over-year increase of 2362.12%. This contributed to the annual value of $701.9 million for FY2025, which is 4560.68% up from last year.
  • Dolby Laboratories' Cash & Equivalents amounted to $643.8 million in Q4 2025, which was up 2362.12% from $701.9 million recorded in Q3 2025.
  • Dolby Laboratories' Cash & Equivalents' 5-year high stood at $1.2 billion during Q3 2021, with a 5-year trough of $482.0 million in Q3 2024.
  • Moreover, its 5-year median value for Cash & Equivalents was $705.7 million (2024), whereas its average is $779.6 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first skyrocketed by 5236.9% in 2021, then crashed by 4939.3% in 2022.
  • Quarter analysis of 5 years shows Dolby Laboratories' Cash & Equivalents stood at $1.1 billion in 2021, then tumbled by 40.74% to $626.2 million in 2022, then grew by 4.9% to $656.8 million in 2023, then dropped by 20.71% to $520.8 million in 2024, then grew by 23.62% to $643.8 million in 2025.
  • Its Cash & Equivalents was $643.8 million in Q4 2025, compared to $701.9 million in Q3 2025 and $698.6 million in Q2 2025.